nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—HTR1D—meninx—malignant glioma	0.0566	0.138	CbGeAlD
Sumatriptan—HTR3A—fourth ventricle—malignant glioma	0.0552	0.134	CbGeAlD
Sumatriptan—HTR1B—dura mater—malignant glioma	0.0538	0.131	CbGeAlD
Sumatriptan—HTR1D—dura mater—malignant glioma	0.0521	0.127	CbGeAlD
Sumatriptan—Monoplegia—Carmustine—malignant glioma	0.0196	0.0492	CcSEcCtD
Sumatriptan—Melatonin—ASMT—malignant glioma	0.0165	0.899	CrCbGaD
Sumatriptan—Dysphasia—Temozolomide—malignant glioma	0.0134	0.0337	CcSEcCtD
Sumatriptan—HTR1B—telencephalic ventricle—malignant glioma	0.0134	0.0326	CbGeAlD
Sumatriptan—HTR1D—telencephalic ventricle—malignant glioma	0.013	0.0316	CbGeAlD
Sumatriptan—HTR1A—telencephalic ventricle—malignant glioma	0.0108	0.0263	CbGeAlD
Sumatriptan—DRD2—telencephalic ventricle—malignant glioma	0.00978	0.0238	CbGeAlD
Sumatriptan—Facial paralysis—Carmustine—malignant glioma	0.00953	0.0239	CcSEcCtD
Sumatriptan—Sensory disturbance—Temozolomide—malignant glioma	0.00945	0.0237	CcSEcCtD
Sumatriptan—Vasospasm—Carmustine—malignant glioma	0.00887	0.0223	CcSEcCtD
Sumatriptan—Hemiplegia—Carmustine—malignant glioma	0.00849	0.0213	CcSEcCtD
Sumatriptan—Hemiplegia—Temozolomide—malignant glioma	0.0082	0.0206	CcSEcCtD
Sumatriptan—HTR1F—telencephalon—malignant glioma	0.00786	0.0191	CbGeAlD
Sumatriptan—VIIth nerve paralysis—Carmustine—malignant glioma	0.00739	0.0186	CcSEcCtD
Sumatriptan—Intracranial pressure increased—Carmustine—malignant glioma	0.00726	0.0182	CcSEcCtD
Sumatriptan—HTR1B—blood vessel—malignant glioma	0.00664	0.0162	CbGeAlD
Sumatriptan—HTR1D—blood vessel—malignant glioma	0.00643	0.0156	CbGeAlD
Sumatriptan—Disorder sight—Temozolomide—malignant glioma	0.00615	0.0155	CcSEcCtD
Sumatriptan—Cerebral ischaemia—Temozolomide—malignant glioma	0.00606	0.0152	CcSEcCtD
Sumatriptan—Transient ischaemic attack—Temozolomide—malignant glioma	0.0058	0.0146	CcSEcCtD
Sumatriptan—Visual acuity reduced—Temozolomide—malignant glioma	0.00492	0.0124	CcSEcCtD
Sumatriptan—Aphasia—Carmustine—malignant glioma	0.00467	0.0117	CcSEcCtD
Sumatriptan—Cyst—Carmustine—malignant glioma	0.00453	0.0114	CcSEcCtD
Sumatriptan—Aphasia—Temozolomide—malignant glioma	0.00452	0.0113	CcSEcCtD
Sumatriptan—HTR1F—central nervous system—malignant glioma	0.00447	0.0109	CbGeAlD
Sumatriptan—Burning sensation—Carmustine—malignant glioma	0.00436	0.011	CcSEcCtD
Sumatriptan—HTR3A—brainstem—malignant glioma	0.00433	0.0105	CbGeAlD
Sumatriptan—Thrombosis—Carmustine—malignant glioma	0.00428	0.0108	CcSEcCtD
Sumatriptan—Myopathy—Temozolomide—malignant glioma	0.00418	0.0105	CcSEcCtD
Sumatriptan—Apathy—Temozolomide—malignant glioma	0.0041	0.0103	CcSEcCtD
Sumatriptan—Flat affect—Temozolomide—malignant glioma	0.00406	0.0102	CcSEcCtD
Sumatriptan—Scotoma—Carmustine—malignant glioma	0.00399	0.01	CcSEcCtD
Sumatriptan—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00389	0.00977	CcSEcCtD
Sumatriptan—Scotoma—Temozolomide—malignant glioma	0.00386	0.00969	CcSEcCtD
Sumatriptan—HTR3A—telencephalon—malignant glioma	0.00384	0.00935	CbGeAlD
Sumatriptan—Hyperaesthesia—Temozolomide—malignant glioma	0.00373	0.00937	CcSEcCtD
Sumatriptan—Memory impairment—Temozolomide—malignant glioma	0.00373	0.00937	CcSEcCtD
Sumatriptan—Injection site pain—Carmustine—malignant glioma	0.00371	0.00932	CcSEcCtD
Sumatriptan—HTR1B—brainstem—malignant glioma	0.00363	0.00883	CbGeAlD
Sumatriptan—HTR1F—brain—malignant glioma	0.00355	0.00863	CbGeAlD
Sumatriptan—Speech disorder—Carmustine—malignant glioma	0.00352	0.00885	CcSEcCtD
Sumatriptan—HTR1D—brainstem—malignant glioma	0.00351	0.00855	CbGeAlD
Sumatriptan—Speech disorder—Temozolomide—malignant glioma	0.00341	0.00855	CcSEcCtD
Sumatriptan—Viral infection—Temozolomide—malignant glioma	0.00324	0.00815	CcSEcCtD
Sumatriptan—HTR1B—telencephalon—malignant glioma	0.00322	0.00784	CbGeAlD
Sumatriptan—HTR1D—telencephalon—malignant glioma	0.00312	0.00759	CbGeAlD
Sumatriptan—Gait disturbance—Carmustine—malignant glioma	0.00311	0.0078	CcSEcCtD
Sumatriptan—Coordination abnormal—Carmustine—malignant glioma	0.00309	0.00775	CcSEcCtD
Sumatriptan—Hearing impaired—Temozolomide—malignant glioma	0.00308	0.00773	CcSEcCtD
Sumatriptan—Neck pain—Carmustine—malignant glioma	0.00307	0.00771	CcSEcCtD
Sumatriptan—Pulmonary embolism—Carmustine—malignant glioma	0.00303	0.00761	CcSEcCtD
Sumatriptan—SLCO1A2—telencephalon—malignant glioma	0.00303	0.00738	CbGeAlD
Sumatriptan—Injection site reaction—Carmustine—malignant glioma	0.00301	0.00757	CcSEcCtD
Sumatriptan—Gait disturbance—Temozolomide—malignant glioma	0.003	0.00754	CcSEcCtD
Sumatriptan—Coordination abnormal—Temozolomide—malignant glioma	0.00298	0.00749	CcSEcCtD
Sumatriptan—Musculoskeletal pain—Temozolomide—malignant glioma	0.00296	0.00745	CcSEcCtD
Sumatriptan—Pulmonary embolism—Temozolomide—malignant glioma	0.00293	0.00736	CcSEcCtD
Sumatriptan—HTR1A—brainstem—malignant glioma	0.00293	0.00713	CbGeAlD
Sumatriptan—MAOA—embryo—malignant glioma	0.00292	0.00711	CbGeAlD
Sumatriptan—Skin exfoliation—Carmustine—malignant glioma	0.00289	0.00727	CcSEcCtD
Sumatriptan—Skin exfoliation—Temozolomide—malignant glioma	0.0028	0.00702	CcSEcCtD
Sumatriptan—MAOA—brainstem—malignant glioma	0.00268	0.00651	CbGeAlD
Sumatriptan—DRD2—brainstem—malignant glioma	0.00265	0.00644	CbGeAlD
Sumatriptan—HTR1A—telencephalon—malignant glioma	0.0026	0.00633	CbGeAlD
Sumatriptan—MAOA—retina—malignant glioma	0.00258	0.00628	CbGeAlD
Sumatriptan—Phlebitis—Carmustine—malignant glioma	0.00255	0.00641	CcSEcCtD
Sumatriptan—DRD2—retina—malignant glioma	0.00255	0.00621	CbGeAlD
Sumatriptan—Thrombophlebitis—Carmustine—malignant glioma	0.00254	0.00638	CcSEcCtD
Sumatriptan—Swelling—Carmustine—malignant glioma	0.00249	0.00626	CcSEcCtD
Sumatriptan—Ear pain—Temozolomide—malignant glioma	0.00249	0.00626	CcSEcCtD
Sumatriptan—Thrombophlebitis—Temozolomide—malignant glioma	0.00246	0.00617	CcSEcCtD
Sumatriptan—Eye pain—Carmustine—malignant glioma	0.00244	0.00612	CcSEcCtD
Sumatriptan—Gastroenteritis—Temozolomide—malignant glioma	0.0024	0.00603	CcSEcCtD
Sumatriptan—SLCO1A2—medulla oblongata—malignant glioma	0.00238	0.0058	CbGeAlD
Sumatriptan—Deafness—Temozolomide—malignant glioma	0.00238	0.00597	CcSEcCtD
Sumatriptan—MAOA—telencephalon—malignant glioma	0.00237	0.00578	CbGeAlD
Sumatriptan—Eye pain—Temozolomide—malignant glioma	0.00236	0.00592	CcSEcCtD
Sumatriptan—DRD2—telencephalon—malignant glioma	0.00235	0.00572	CbGeAlD
Sumatriptan—HTR1B—midbrain—malignant glioma	0.00231	0.00563	CbGeAlD
Sumatriptan—HTR1B—spinal cord—malignant glioma	0.00226	0.00549	CbGeAlD
Sumatriptan—HTR1D—midbrain—malignant glioma	0.00224	0.00545	CbGeAlD
Sumatriptan—Thirst—Temozolomide—malignant glioma	0.00223	0.00561	CcSEcCtD
Sumatriptan—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.0022	0.00553	CcSEcCtD
Sumatriptan—Diplopia—Carmustine—malignant glioma	0.0022	0.00553	CcSEcCtD
Sumatriptan—HTR3A—central nervous system—malignant glioma	0.00218	0.00531	CbGeAlD
Sumatriptan—SLCO1A2—midbrain—malignant glioma	0.00218	0.0053	CbGeAlD
Sumatriptan—Diplopia—Temozolomide—malignant glioma	0.00213	0.00534	CcSEcCtD
Sumatriptan—SLCO1A2—spinal cord—malignant glioma	0.00212	0.00517	CbGeAlD
Sumatriptan—ABCB1—blood vessel—malignant glioma	0.00209	0.00509	CbGeAlD
Sumatriptan—ABCG2—telencephalon—malignant glioma	0.00206	0.00501	CbGeAlD
Sumatriptan—Liver function test abnormal—Carmustine—malignant glioma	0.00203	0.0051	CcSEcCtD
Sumatriptan—Dehydration—Temozolomide—malignant glioma	0.00198	0.00497	CcSEcCtD
Sumatriptan—Dysphagia—Carmustine—malignant glioma	0.0019	0.00478	CcSEcCtD
Sumatriptan—HTR1A—midbrain—malignant glioma	0.00187	0.00454	CbGeAlD
Sumatriptan—MAOA—medulla oblongata—malignant glioma	0.00187	0.00454	CbGeAlD
Sumatriptan—Eletriptan—PTGS1—malignant glioma	0.00186	0.101	CrCbGaD
Sumatriptan—Abdominal distension—Temozolomide—malignant glioma	0.00185	0.00465	CcSEcCtD
Sumatriptan—Dysphagia—Temozolomide—malignant glioma	0.00184	0.00462	CcSEcCtD
Sumatriptan—HTR1B—central nervous system—malignant glioma	0.00183	0.00446	CbGeAlD
Sumatriptan—HTR1A—spinal cord—malignant glioma	0.00182	0.00443	CbGeAlD
Sumatriptan—Pancytopenia—Carmustine—malignant glioma	0.00181	0.00454	CcSEcCtD
Sumatriptan—HTR1D—central nervous system—malignant glioma	0.00177	0.00431	CbGeAlD
Sumatriptan—Bronchitis—Temozolomide—malignant glioma	0.00177	0.00444	CcSEcCtD
Sumatriptan—Pancytopenia—Temozolomide—malignant glioma	0.00175	0.00438	CcSEcCtD
Sumatriptan—HTR3A—brain—malignant glioma	0.00173	0.00422	CbGeAlD
Sumatriptan—SLCO1A2—central nervous system—malignant glioma	0.00172	0.00419	CbGeAlD
Sumatriptan—Dysuria—Temozolomide—malignant glioma	0.00172	0.00432	CcSEcCtD
Sumatriptan—Hyperglycaemia—Carmustine—malignant glioma	0.00172	0.00431	CcSEcCtD
Sumatriptan—MAOA—midbrain—malignant glioma	0.00171	0.00415	CbGeAlD
Sumatriptan—Pollakiuria—Temozolomide—malignant glioma	0.0017	0.00426	CcSEcCtD
Sumatriptan—Depression—Carmustine—malignant glioma	0.00169	0.00425	CcSEcCtD
Sumatriptan—DRD2—midbrain—malignant glioma	0.00169	0.00411	CbGeAlD
Sumatriptan—SLCO1A2—cerebellum—malignant glioma	0.00168	0.0041	CbGeAlD
Sumatriptan—Photosensitivity reaction—Temozolomide—malignant glioma	0.00168	0.00421	CcSEcCtD
Sumatriptan—Weight increased—Temozolomide—malignant glioma	0.00167	0.0042	CcSEcCtD
Sumatriptan—MAOA—spinal cord—malignant glioma	0.00166	0.00405	CbGeAlD
Sumatriptan—Weight decreased—Temozolomide—malignant glioma	0.00166	0.00418	CcSEcCtD
Sumatriptan—Hyperglycaemia—Temozolomide—malignant glioma	0.00166	0.00416	CcSEcCtD
Sumatriptan—Depression—Temozolomide—malignant glioma	0.00163	0.0041	CcSEcCtD
Sumatriptan—ABCG2—medulla oblongata—malignant glioma	0.00162	0.00394	CbGeAlD
Sumatriptan—Sinusitis—Temozolomide—malignant glioma	0.00154	0.00386	CcSEcCtD
Sumatriptan—Haemoglobin—Carmustine—malignant glioma	0.00153	0.00384	CcSEcCtD
Sumatriptan—Haemorrhage—Carmustine—malignant glioma	0.00152	0.00382	CcSEcCtD
Sumatriptan—Hallucination—Carmustine—malignant glioma	0.00151	0.0038	CcSEcCtD
Sumatriptan—Hypoaesthesia—Carmustine—malignant glioma	0.00151	0.0038	CcSEcCtD
Sumatriptan—Connective tissue disorder—Carmustine—malignant glioma	0.0015	0.00376	CcSEcCtD
Sumatriptan—Haemoglobin—Temozolomide—malignant glioma	0.00148	0.00371	CcSEcCtD
Sumatriptan—ABCG2—midbrain—malignant glioma	0.00148	0.0036	CbGeAlD
Sumatriptan—HTR1A—central nervous system—malignant glioma	0.00148	0.0036	CbGeAlD
Sumatriptan—Haemorrhage—Temozolomide—malignant glioma	0.00147	0.00369	CcSEcCtD
Sumatriptan—Visual impairment—Carmustine—malignant glioma	0.00147	0.00368	CcSEcCtD
Sumatriptan—Hypoaesthesia—Temozolomide—malignant glioma	0.00146	0.00368	CcSEcCtD
Sumatriptan—Hallucination—Temozolomide—malignant glioma	0.00146	0.00368	CcSEcCtD
Sumatriptan—HTR1B—brain—malignant glioma	0.00145	0.00354	CbGeAlD
Sumatriptan—Connective tissue disorder—Temozolomide—malignant glioma	0.00145	0.00363	CcSEcCtD
Sumatriptan—HTR1A—cerebellum—malignant glioma	0.00144	0.00351	CbGeAlD
Sumatriptan—ABCG2—spinal cord—malignant glioma	0.00144	0.00351	CbGeAlD
Sumatriptan—Eye disorder—Carmustine—malignant glioma	0.00142	0.00357	CcSEcCtD
Sumatriptan—Visual impairment—Temozolomide—malignant glioma	0.00142	0.00356	CcSEcCtD
Sumatriptan—Flushing—Carmustine—malignant glioma	0.00141	0.00355	CcSEcCtD
Sumatriptan—HTR1D—brain—malignant glioma	0.00141	0.00343	CbGeAlD
Sumatriptan—Eye disorder—Temozolomide—malignant glioma	0.00137	0.00345	CcSEcCtD
Sumatriptan—Tinnitus—Temozolomide—malignant glioma	0.00137	0.00344	CcSEcCtD
Sumatriptan—SLCO1A2—brain—malignant glioma	0.00137	0.00333	CbGeAlD
Sumatriptan—Flushing—Temozolomide—malignant glioma	0.00137	0.00343	CcSEcCtD
Sumatriptan—Arrhythmia—Carmustine—malignant glioma	0.00136	0.00342	CcSEcCtD
Sumatriptan—MAOA—central nervous system—malignant glioma	0.00135	0.00329	CbGeAlD
Sumatriptan—DRD2—central nervous system—malignant glioma	0.00133	0.00325	CbGeAlD
Sumatriptan—Angiopathy—Temozolomide—malignant glioma	0.00133	0.00335	CcSEcCtD
Sumatriptan—Immune system disorder—Temozolomide—malignant glioma	0.00133	0.00334	CcSEcCtD
Sumatriptan—Mediastinal disorder—Temozolomide—malignant glioma	0.00133	0.00333	CcSEcCtD
Sumatriptan—Erythema—Carmustine—malignant glioma	0.00133	0.00333	CcSEcCtD
Sumatriptan—Chills—Temozolomide—malignant glioma	0.00132	0.00331	CcSEcCtD
Sumatriptan—MAOA—cerebellum—malignant glioma	0.00132	0.00321	CbGeAlD
Sumatriptan—DRD2—cerebellum—malignant glioma	0.0013	0.00318	CbGeAlD
Sumatriptan—Back pain—Carmustine—malignant glioma	0.00128	0.00322	CcSEcCtD
Sumatriptan—Erythema—Temozolomide—malignant glioma	0.00128	0.00322	CcSEcCtD
Sumatriptan—Dysgeusia—Temozolomide—malignant glioma	0.00125	0.00315	CcSEcCtD
Sumatriptan—ABCB1—embryo—malignant glioma	0.00125	0.00304	CbGeAlD
Sumatriptan—Tremor—Carmustine—malignant glioma	0.00124	0.00312	CcSEcCtD
Sumatriptan—Back pain—Temozolomide—malignant glioma	0.00124	0.00311	CcSEcCtD
Sumatriptan—Anaemia—Carmustine—malignant glioma	0.00122	0.00308	CcSEcCtD
Sumatriptan—Agitation—Carmustine—malignant glioma	0.00122	0.00306	CcSEcCtD
Sumatriptan—Tremor—Temozolomide—malignant glioma	0.0012	0.00301	CcSEcCtD
Sumatriptan—Ill-defined disorder—Temozolomide—malignant glioma	0.00119	0.00298	CcSEcCtD
Sumatriptan—Anaemia—Temozolomide—malignant glioma	0.00118	0.00297	CcSEcCtD
Sumatriptan—Agitation—Temozolomide—malignant glioma	0.00118	0.00296	CcSEcCtD
Sumatriptan—HTR1A—brain—malignant glioma	0.00117	0.00285	CbGeAlD
Sumatriptan—Angioedema—Temozolomide—malignant glioma	0.00117	0.00294	CcSEcCtD
Sumatriptan—Malaise—Temozolomide—malignant glioma	0.00115	0.0029	CcSEcCtD
Sumatriptan—Vertigo—Temozolomide—malignant glioma	0.00115	0.00289	CcSEcCtD
Sumatriptan—Convulsion—Carmustine—malignant glioma	0.00115	0.00288	CcSEcCtD
Sumatriptan—Hypertension—Carmustine—malignant glioma	0.00114	0.00287	CcSEcCtD
Sumatriptan—ABCG2—cerebellum—malignant glioma	0.00114	0.00278	CbGeAlD
Sumatriptan—Palpitations—Temozolomide—malignant glioma	0.00113	0.00284	CcSEcCtD
Sumatriptan—Myalgia—Carmustine—malignant glioma	0.00113	0.00283	CcSEcCtD
Sumatriptan—Chest pain—Carmustine—malignant glioma	0.00113	0.00283	CcSEcCtD
Sumatriptan—Anxiety—Carmustine—malignant glioma	0.00112	0.00282	CcSEcCtD
Sumatriptan—Cough—Temozolomide—malignant glioma	0.00112	0.00281	CcSEcCtD
Sumatriptan—Convulsion—Temozolomide—malignant glioma	0.00111	0.00279	CcSEcCtD
Sumatriptan—Hypertension—Temozolomide—malignant glioma	0.00111	0.00278	CcSEcCtD
Sumatriptan—ABCB1—retina—malignant glioma	0.0011	0.00269	CbGeAlD
Sumatriptan—Confusional state—Carmustine—malignant glioma	0.00109	0.00274	CcSEcCtD
Sumatriptan—Arthralgia—Temozolomide—malignant glioma	0.00109	0.00274	CcSEcCtD
Sumatriptan—Myalgia—Temozolomide—malignant glioma	0.00109	0.00274	CcSEcCtD
Sumatriptan—Anxiety—Temozolomide—malignant glioma	0.00109	0.00273	CcSEcCtD
Sumatriptan—Oedema—Carmustine—malignant glioma	0.00108	0.00272	CcSEcCtD
Sumatriptan—Discomfort—Temozolomide—malignant glioma	0.00108	0.00271	CcSEcCtD
Sumatriptan—Infection—Carmustine—malignant glioma	0.00107	0.0027	CcSEcCtD
Sumatriptan—MAOA—brain—malignant glioma	0.00107	0.00261	CbGeAlD
Sumatriptan—Dry mouth—Temozolomide—malignant glioma	0.00107	0.00268	CcSEcCtD
Sumatriptan—DRD2—brain—malignant glioma	0.00106	0.00258	CbGeAlD
Sumatriptan—Thrombocytopenia—Carmustine—malignant glioma	0.00106	0.00266	CcSEcCtD
Sumatriptan—Tachycardia—Carmustine—malignant glioma	0.00106	0.00265	CcSEcCtD
Sumatriptan—Confusional state—Temozolomide—malignant glioma	0.00105	0.00265	CcSEcCtD
Sumatriptan—Oedema—Temozolomide—malignant glioma	0.00105	0.00262	CcSEcCtD
Sumatriptan—Anaphylactic shock—Temozolomide—malignant glioma	0.00105	0.00262	CcSEcCtD
Sumatriptan—Infection—Temozolomide—malignant glioma	0.00104	0.00261	CcSEcCtD
Sumatriptan—Nervous system disorder—Temozolomide—malignant glioma	0.00102	0.00257	CcSEcCtD
Sumatriptan—Thrombocytopenia—Temozolomide—malignant glioma	0.00102	0.00257	CcSEcCtD
Sumatriptan—Skin disorder—Temozolomide—malignant glioma	0.00102	0.00255	CcSEcCtD
Sumatriptan—ABCB1—telencephalon—malignant glioma	0.00102	0.00247	CbGeAlD
Sumatriptan—Hypotension—Carmustine—malignant glioma	0.00101	0.00254	CcSEcCtD
Sumatriptan—Hyperhidrosis—Temozolomide—malignant glioma	0.00101	0.00254	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000985	0.00247	CcSEcCtD
Sumatriptan—Paraesthesia—Carmustine—malignant glioma	0.000971	0.00244	CcSEcCtD
Sumatriptan—Dyspnoea—Carmustine—malignant glioma	0.000964	0.00242	CcSEcCtD
Sumatriptan—Somnolence—Carmustine—malignant glioma	0.000961	0.00241	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000952	0.00239	CcSEcCtD
Sumatriptan—Decreased appetite—Carmustine—malignant glioma	0.00094	0.00236	CcSEcCtD
Sumatriptan—Paraesthesia—Temozolomide—malignant glioma	0.000938	0.00236	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Carmustine—malignant glioma	0.000934	0.00234	CcSEcCtD
Sumatriptan—Dyspnoea—Temozolomide—malignant glioma	0.000932	0.00234	CcSEcCtD
Sumatriptan—Somnolence—Temozolomide—malignant glioma	0.000929	0.00233	CcSEcCtD
Sumatriptan—ABCG2—brain—malignant glioma	0.000929	0.00226	CbGeAlD
Sumatriptan—Pain—Carmustine—malignant glioma	0.000925	0.00232	CcSEcCtD
Sumatriptan—Constipation—Carmustine—malignant glioma	0.000925	0.00232	CcSEcCtD
Sumatriptan—Decreased appetite—Temozolomide—malignant glioma	0.000908	0.00228	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000902	0.00227	CcSEcCtD
Sumatriptan—Fatigue—Temozolomide—malignant glioma	0.000901	0.00226	CcSEcCtD
Sumatriptan—Pain—Temozolomide—malignant glioma	0.000894	0.00224	CcSEcCtD
Sumatriptan—Constipation—Temozolomide—malignant glioma	0.000894	0.00224	CcSEcCtD
Sumatriptan—Feeling abnormal—Carmustine—malignant glioma	0.000891	0.00224	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Carmustine—malignant glioma	0.000884	0.00222	CcSEcCtD
Sumatriptan—Feeling abnormal—Temozolomide—malignant glioma	0.000861	0.00216	CcSEcCtD
Sumatriptan—Abdominal pain—Carmustine—malignant glioma	0.000855	0.00215	CcSEcCtD
Sumatriptan—Body temperature increased—Carmustine—malignant glioma	0.000855	0.00215	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Temozolomide—malignant glioma	0.000855	0.00215	CcSEcCtD
Sumatriptan—Urticaria—Temozolomide—malignant glioma	0.00083	0.00209	CcSEcCtD
Sumatriptan—Body temperature increased—Temozolomide—malignant glioma	0.000826	0.00207	CcSEcCtD
Sumatriptan—Abdominal pain—Temozolomide—malignant glioma	0.000826	0.00207	CcSEcCtD
Sumatriptan—ABCB1—medulla oblongata—malignant glioma	0.000798	0.00194	CbGeAlD
Sumatriptan—Hypersensitivity—Carmustine—malignant glioma	0.000797	0.002	CcSEcCtD
Sumatriptan—Asthenia—Carmustine—malignant glioma	0.000776	0.00195	CcSEcCtD
Sumatriptan—Hypersensitivity—Temozolomide—malignant glioma	0.00077	0.00193	CcSEcCtD
Sumatriptan—Asthenia—Temozolomide—malignant glioma	0.00075	0.00188	CcSEcCtD
Sumatriptan—Diarrhoea—Carmustine—malignant glioma	0.00074	0.00186	CcSEcCtD
Sumatriptan—Pruritus—Temozolomide—malignant glioma	0.000739	0.00186	CcSEcCtD
Sumatriptan—ABCB1—midbrain—malignant glioma	0.000729	0.00177	CbGeAlD
Sumatriptan—Dizziness—Carmustine—malignant glioma	0.000715	0.0018	CcSEcCtD
Sumatriptan—Diarrhoea—Temozolomide—malignant glioma	0.000715	0.0018	CcSEcCtD
Sumatriptan—ABCB1—spinal cord—malignant glioma	0.000711	0.00173	CbGeAlD
Sumatriptan—Dizziness—Temozolomide—malignant glioma	0.000691	0.00174	CcSEcCtD
Sumatriptan—Vomiting—Carmustine—malignant glioma	0.000688	0.00173	CcSEcCtD
Sumatriptan—Rash—Carmustine—malignant glioma	0.000682	0.00171	CcSEcCtD
Sumatriptan—Dermatitis—Carmustine—malignant glioma	0.000681	0.00171	CcSEcCtD
Sumatriptan—Headache—Carmustine—malignant glioma	0.000677	0.0017	CcSEcCtD
Sumatriptan—Vomiting—Temozolomide—malignant glioma	0.000664	0.00167	CcSEcCtD
Sumatriptan—Rash—Temozolomide—malignant glioma	0.000659	0.00165	CcSEcCtD
Sumatriptan—Dermatitis—Temozolomide—malignant glioma	0.000658	0.00165	CcSEcCtD
Sumatriptan—Headache—Temozolomide—malignant glioma	0.000655	0.00164	CcSEcCtD
Sumatriptan—Nausea—Carmustine—malignant glioma	0.000642	0.00161	CcSEcCtD
Sumatriptan—Nausea—Temozolomide—malignant glioma	0.000621	0.00156	CcSEcCtD
Sumatriptan—ABCB1—central nervous system—malignant glioma	0.000577	0.0014	CbGeAlD
Sumatriptan—ABCB1—cerebellum—malignant glioma	0.000564	0.00137	CbGeAlD
Sumatriptan—ABCB1—brain—malignant glioma	0.000458	0.00111	CbGeAlD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CB—malignant glioma	3.59e-05	0.000208	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CAV1—malignant glioma	3.58e-05	0.000207	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KDR—malignant glioma	3.58e-05	0.000207	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN2B—malignant glioma	3.57e-05	0.000207	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KNG1—malignant glioma	3.57e-05	0.000206	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CG—malignant glioma	3.53e-05	0.000205	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FN1—malignant glioma	3.52e-05	0.000204	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—F2—malignant glioma	3.52e-05	0.000204	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—malignant glioma	3.51e-05	0.000203	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PTEN—malignant glioma	3.49e-05	0.000202	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—BAD—malignant glioma	3.48e-05	0.000201	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTK2—malignant glioma	3.46e-05	0.000201	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTT1—malignant glioma	3.45e-05	0.0002	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL8—malignant glioma	3.45e-05	0.0002	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FN1—malignant glioma	3.45e-05	0.0002	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—F2—malignant glioma	3.45e-05	0.0002	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NOTCH1—malignant glioma	3.44e-05	0.000199	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.42e-05	0.000198	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT2—malignant glioma	3.42e-05	0.000198	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PPARG—malignant glioma	3.41e-05	0.000198	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—BAD—malignant glioma	3.4e-05	0.000197	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HES1—malignant glioma	3.4e-05	0.000197	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—AKT1—malignant glioma	3.4e-05	0.000197	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NTRK1—malignant glioma	3.4e-05	0.000197	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NCOR1—malignant glioma	3.38e-05	0.000196	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CD80—malignant glioma	3.37e-05	0.000195	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NOTCH1—malignant glioma	3.37e-05	0.000195	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CG—malignant glioma	3.37e-05	0.000195	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APC—malignant glioma	3.37e-05	0.000195	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CD—malignant glioma	3.35e-05	0.000194	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.35e-05	0.000194	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—RAF1—malignant glioma	3.34e-05	0.000193	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGF—malignant glioma	3.33e-05	0.000193	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CAV1—malignant glioma	3.32e-05	0.000192	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTPN11—malignant glioma	3.31e-05	0.000192	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CD80—malignant glioma	3.3e-05	0.000191	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CG—malignant glioma	3.3e-05	0.000191	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APC—malignant glioma	3.3e-05	0.000191	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL2—malignant glioma	3.3e-05	0.000191	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CD—malignant glioma	3.28e-05	0.00019	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CG—malignant glioma	3.26e-05	0.000189	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGF—malignant glioma	3.26e-05	0.000189	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CB—malignant glioma	3.26e-05	0.000189	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PDGFRA—malignant glioma	3.24e-05	0.000188	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTPN11—malignant glioma	3.24e-05	0.000188	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS1—malignant glioma	3.23e-05	0.000187	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—BRAF—malignant glioma	3.17e-05	0.000183	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP3—malignant glioma	3.16e-05	0.000183	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CB—malignant glioma	3.15e-05	0.000182	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—malignant glioma	3.15e-05	0.000182	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PPARG—malignant glioma	3.15e-05	0.000182	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SPP1—malignant glioma	3.15e-05	0.000182	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN2B—malignant glioma	3.13e-05	0.000181	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL8—malignant glioma	3.13e-05	0.000181	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—STAT3—malignant glioma	3.12e-05	0.000181	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CD—malignant glioma	3.11e-05	0.00018	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—BRAF—malignant glioma	3.1e-05	0.000179	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT2—malignant glioma	3.08e-05	0.000178	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EGFR—malignant glioma	3.07e-05	0.000178	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTK2—malignant glioma	3.04e-05	0.000176	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL8—malignant glioma	3.03e-05	0.000175	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CG—malignant glioma	3.02e-05	0.000175	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT2—malignant glioma	3.02e-05	0.000175	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—BCHE—malignant glioma	3.01e-05	0.000174	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EGFR—malignant glioma	3e-05	0.000174	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2—malignant glioma	2.99e-05	0.000173	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HES1—malignant glioma	2.99e-05	0.000173	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TERT—malignant glioma	2.98e-05	0.000173	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC5A5—malignant glioma	2.97e-05	0.000172	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NCOR1—malignant glioma	2.97e-05	0.000172	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CD—malignant glioma	2.96e-05	0.000171	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—PIK3CA—malignant glioma	2.93e-05	0.00017	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RAF1—malignant glioma	2.93e-05	0.00017	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CB—malignant glioma	2.92e-05	0.000169	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARG—malignant glioma	2.91e-05	0.000169	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PDGFB—malignant glioma	2.91e-05	0.000169	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CD—malignant glioma	2.9e-05	0.000168	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—KRAS—malignant glioma	2.9e-05	0.000168	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—malignant glioma	2.9e-05	0.000168	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—malignant glioma	2.9e-05	0.000168	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGFR1—malignant glioma	2.9e-05	0.000168	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2—malignant glioma	2.89e-05	0.000168	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PIK3CA—malignant glioma	2.87e-05	0.000166	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CD—malignant glioma	2.87e-05	0.000166	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CB—malignant glioma	2.86e-05	0.000166	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HIF1A—malignant glioma	2.85e-05	0.000165	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PDGFRA—malignant glioma	2.84e-05	0.000165	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—KRAS—malignant glioma	2.84e-05	0.000164	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FGF2—malignant glioma	2.83e-05	0.000164	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—malignant glioma	2.83e-05	0.000164	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGF2—malignant glioma	2.78e-05	0.000161	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SPP1—malignant glioma	2.76e-05	0.00016	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CAV1—malignant glioma	2.76e-05	0.00016	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL8—malignant glioma	2.75e-05	0.000159	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.74e-05	0.000158	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KDR—malignant glioma	2.73e-05	0.000158	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CB—malignant glioma	2.71e-05	0.000157	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—malignant glioma	2.68e-05	0.000155	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KRAS—malignant glioma	2.68e-05	0.000155	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PIK3CA—malignant glioma	2.66e-05	0.000154	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CD—malignant glioma	2.65e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MDM2—malignant glioma	2.65e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RAF1—malignant glioma	2.64e-05	0.000153	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2—malignant glioma	2.63e-05	0.000152	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—F2—malignant glioma	2.62e-05	0.000152	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FN1—malignant glioma	2.62e-05	0.000152	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TERT—malignant glioma	2.62e-05	0.000152	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ERBB2—malignant glioma	2.61e-05	0.000151	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PIK3CA—malignant glioma	2.61e-05	0.000151	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MDM2—malignant glioma	2.6e-05	0.00015	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BAD—malignant glioma	2.59e-05	0.00015	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RAF1—malignant glioma	2.59e-05	0.00015	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CB—malignant glioma	2.58e-05	0.000149	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NOTCH1—malignant glioma	2.57e-05	0.000149	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ERBB2—malignant glioma	2.56e-05	0.000148	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PDGFB—malignant glioma	2.56e-05	0.000148	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGFR1—malignant glioma	2.54e-05	0.000147	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CB—malignant glioma	2.53e-05	0.000146	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTEN—malignant glioma	2.53e-05	0.000146	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CD80—malignant glioma	2.52e-05	0.000146	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APC—malignant glioma	2.51e-05	0.000145	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CG—malignant glioma	2.51e-05	0.000145	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HIF1A—malignant glioma	2.5e-05	0.000145	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CB—malignant glioma	2.5e-05	0.000145	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGF—malignant glioma	2.48e-05	0.000144	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL8—malignant glioma	2.48e-05	0.000144	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—malignant glioma	2.48e-05	0.000143	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTPN11—malignant glioma	2.47e-05	0.000143	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CA—malignant glioma	2.46e-05	0.000142	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL8—malignant glioma	2.43e-05	0.000141	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CAV1—malignant glioma	2.42e-05	0.00014	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AKT1—malignant glioma	2.4e-05	0.000139	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KDR—malignant glioma	2.39e-05	0.000139	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—malignant glioma	2.39e-05	0.000139	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—malignant glioma	2.38e-05	0.000138	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—malignant glioma	2.37e-05	0.000137	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2—malignant glioma	2.37e-05	0.000137	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BRAF—malignant glioma	2.36e-05	0.000137	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AKT1—malignant glioma	2.35e-05	0.000136	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTEN—malignant glioma	2.34e-05	0.000136	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAT—malignant glioma	2.33e-05	0.000135	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—malignant glioma	2.32e-05	0.000135	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2—malignant glioma	2.32e-05	0.000134	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CB—malignant glioma	2.31e-05	0.000134	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—F2—malignant glioma	2.3e-05	0.000133	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FN1—malignant glioma	2.3e-05	0.000133	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT2—malignant glioma	2.3e-05	0.000133	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—malignant glioma	2.29e-05	0.000133	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—malignant glioma	2.29e-05	0.000133	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BAD—malignant glioma	2.28e-05	0.000132	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOTCH1—malignant glioma	2.26e-05	0.000131	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—malignant glioma	2.24e-05	0.00013	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTEN—malignant glioma	2.23e-05	0.000129	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CD80—malignant glioma	2.21e-05	0.000128	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	2.21e-05	0.000128	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APC—malignant glioma	2.21e-05	0.000128	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CG—malignant glioma	2.21e-05	0.000128	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NCOR1—malignant glioma	2.2e-05	0.000127	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—malignant glioma	2.2e-05	0.000127	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	2.19e-05	0.000127	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTEN—malignant glioma	2.18e-05	0.000126	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGF—malignant glioma	2.18e-05	0.000126	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AKT1—malignant glioma	2.18e-05	0.000126	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTPN11—malignant glioma	2.17e-05	0.000125	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—KRAS—malignant glioma	2.16e-05	0.000125	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTEN—malignant glioma	2.16e-05	0.000125	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AKT1—malignant glioma	2.13e-05	0.000123	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGF2—malignant glioma	2.11e-05	0.000122	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BRAF—malignant glioma	2.07e-05	0.00012	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT2—malignant glioma	2.02e-05	0.000117	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—malignant glioma	2.01e-05	0.000117	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKT1—malignant glioma	2.01e-05	0.000116	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—malignant glioma	2.01e-05	0.000116	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTEN—malignant glioma	2e-05	0.000116	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT3—malignant glioma	1.99e-05	0.000115	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	1.99e-05	0.000115	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MDM2—malignant glioma	1.98e-05	0.000115	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—malignant glioma	1.97e-05	0.000114	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RAF1—malignant glioma	1.97e-05	0.000114	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT3—malignant glioma	1.95e-05	0.000113	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ERBB2—malignant glioma	1.95e-05	0.000113	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CD—malignant glioma	1.94e-05	0.000112	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	1.92e-05	0.000111	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	1.92e-05	0.000111	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—KRAS—malignant glioma	1.9e-05	0.00011	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGF2—malignant glioma	1.86e-05	0.000108	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—malignant glioma	1.85e-05	0.000107	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL8—malignant glioma	1.85e-05	0.000107	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—malignant glioma	1.81e-05	0.000105	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—malignant glioma	1.81e-05	0.000105	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAV1—malignant glioma	1.79e-05	0.000104	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	1.79e-05	0.000103	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CA—malignant glioma	1.78e-05	0.000103	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—malignant glioma	1.77e-05	0.000103	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—malignant glioma	1.77e-05	0.000103	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2—malignant glioma	1.77e-05	0.000102	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	1.74e-05	0.000101	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MDM2—malignant glioma	1.74e-05	0.000101	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RAF1—malignant glioma	1.73e-05	0.0001	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ERBB2—malignant glioma	1.71e-05	9.92e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KRAS—malignant glioma	1.71e-05	9.92e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CB—malignant glioma	1.69e-05	9.79e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KRAS—malignant glioma	1.68e-05	9.71e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—malignant glioma	1.67e-05	9.69e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTEN—malignant glioma	1.66e-05	9.63e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CA—malignant glioma	1.65e-05	9.56e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CG—malignant glioma	1.63e-05	9.46e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL8—malignant glioma	1.62e-05	9.4e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AKT1—malignant glioma	1.62e-05	9.4e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARG—malignant glioma	1.58e-05	9.13e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	1.57e-05	9.11e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AKT1—malignant glioma	1.57e-05	9.09e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—malignant glioma	1.55e-05	9e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2—malignant glioma	1.55e-05	8.99e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	1.54e-05	8.92e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CA—malignant glioma	1.52e-05	8.82e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—malignant glioma	1.52e-05	8.81e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—malignant glioma	1.5e-05	8.7e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—malignant glioma	1.49e-05	8.63e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT3—malignant glioma	1.49e-05	8.61e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—malignant glioma	1.47e-05	8.51e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTEN—malignant glioma	1.46e-05	8.46e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AKT1—malignant glioma	1.46e-05	8.43e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CD—malignant glioma	1.44e-05	8.31e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT1—malignant glioma	1.42e-05	8.25e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CA—malignant glioma	1.41e-05	8.17e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—malignant glioma	1.38e-05	8e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—malignant glioma	1.35e-05	7.83e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AKT1—malignant glioma	1.35e-05	7.81e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—malignant glioma	1.32e-05	7.64e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT3—malignant glioma	1.31e-05	7.56e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT1—malignant glioma	1.29e-05	7.44e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KRAS—malignant glioma	1.28e-05	7.4e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT1—malignant glioma	1.26e-05	7.29e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CB—malignant glioma	1.25e-05	7.25e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AKT1—malignant glioma	1.24e-05	7.21e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—malignant glioma	1.24e-05	7.18e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—malignant glioma	1.21e-05	7.03e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—malignant glioma	1.19e-05	6.87e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	1.17e-05	6.8e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AKT1—malignant glioma	1.15e-05	6.67e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—malignant glioma	1.14e-05	6.57e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KRAS—malignant glioma	1.12e-05	6.49e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTEN—malignant glioma	1.08e-05	6.26e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CA—malignant glioma	1.03e-05	5.97e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—malignant glioma	9.97e-06	5.77e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT1—malignant glioma	9.59e-06	5.55e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT1—malignant glioma	8.42e-06	4.87e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CA—malignant glioma	7.63e-06	4.42e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKT1—malignant glioma	6.23e-06	3.61e-05	CbGpPWpGaD
